Disease-Modifying Treatment in Progressive Multiple Sclerosis

被引：0
|
作者：
John Robert Ciotti
Anne Haney Cross
机构：
[1] Washington University in St. Louis,
来源：
Current Treatment Options in Neurology | 2018年 / 20卷
关键词：
Progressive multiple sclerosis; Disease-modifying therapy; Neuroprotection; Remyelination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Update on Disease-Modifying Treatments for Multiple Sclerosis
    Carrithers, Michael D.
    CLINICAL THERAPEUTICS, 2014, 36 (12) : 1938 - 1945
  • [32] Using disease-modifying therapies for multiple sclerosis
    不详
    JOURNAL OF ADVANCED NURSING, 2004, 48 (03) : 314 - 314
  • [33] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
    Chitnis, Tanuja
    NEUROTHERAPEUTICS, 2013, 10 (01) : 89 - 96
  • [34] Current disease-modifying therapies in multiple sclerosis
    Kieseier, BC
    Hartung, HP
    SEMINARS IN NEUROLOGY, 2003, 23 (02) : 133 - 145
  • [35] Stoppers and non-starters of disease-modifying treatment in multiple sclerosis
    Grytten, N.
    Aarseth, J. H.
    Espeset, K.
    Johnsen, G. B.
    Wehus, R.
    Lund, C.
    Haugstad, R. C.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 127 (02): : 133 - 140
  • [36] Teriflunomide: An orally administered disease-modifying drug for the treatment of multiple sclerosis
    Wojtusik, Amanda
    Feret, Brett
    FORMULARY, 2012, 47 (03) : 97 - 102
  • [37] Rebound after discontinuing prolonged disease-modifying treatment for Multiple Sclerosis
    Eichau, Sara
    Perez-Sanchez, Soledad
    Dominguez-Mayoral, Ana
    Dolores Paramo, Maria
    Rus-Hidalgo, Macarena
    Ruiz Pena, Juan Luis
    Navarro, Guillermo
    Izquierdo, Guillermo
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 25 - 26
  • [38] Audit of patients switching disease-modifying therapies for the treatment of multiple sclerosis
    Embrey, NH
    Woolmore, JA
    Hawkins, CP
    MULTIPLE SCLEROSIS, 2005, 11 : S159 - S159
  • [39] Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis
    Zettl, U. K.
    Schreiber, H.
    Bauer-Steinhusen, U.
    Glaser, T.
    Hechenbichler, K.
    Hecker, M.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (02): : 116 - 121
  • [40] Evoked potentials predict disease-modifying treatment response in multiple sclerosis
    Leocani, L.
    Bianco, M.
    Di Maggio, G.
    Medaglini, S.
    Gonzalez-Rosa, J.
    Chieffo, R.
    Del Carro, U.
    Moiola, L.
    Martinelli, V.
    Comi, G.
    JOURNAL OF NEUROLOGY, 2013, 260 : S15 - S15
12345